[{"id":"a03274aa-74a4-406f-a053-3e21751cf92e","acronym":"GAIA-102-PD","url":"https://clinicaltrials.gov/study/NCT05438459","created_at":"2022-06-30T17:02:10.812Z","updated_at":"2024-07-02T16:36:08.085Z","phase":"Phase 1/2","brief_title":"GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites","source_id_and_acronym":"NCT05438459 - GAIA-102-PD","lead_sponsor":"Kyushu University","biomarkers":" CXCL10 • CXCL9 • CCL20 • CXCL11","pipe":"","alterations":" ","tags":["CXCL10 • CXCL9 • CCL20 • CXCL11"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • GAIA-102"],"overall_status":"Recruiting","enrollment":" Enrollment 96","initiation":"Initiation: 06/08/2022","start_date":" 06/08/2022","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 06/08/2027","study_completion_date":" 06/08/2027","last_update_posted":"2022-06-30"}]